BiotechTubeBiotechTube
Home/Pipeline/New Generic Filings (e.g., for US/EU)

New Generic Filings (e.g., for US/EU)

Various

Regulatory ReviewFiled/Under Development

Key Facts

Indication
Various
Phase
Regulatory Review
Status
Filed/Under Development
Company
Bliss GVS Pharma

About Bliss GVS Pharma

Bliss GVS Pharma is a vertically integrated pharmaceutical company with core strengths in anti-malarials, anti-infectives, and a growing portfolio in other therapeutic areas. The company operates through its manufacturing facilities in India and has established a strong commercial footprint in over 70 countries. Its strategic direction involves expanding its product portfolio through in-house R&D and strategic partnerships, while leveraging its manufacturing capabilities to serve regulated and semi-regulated markets.

View full company profile

Therapeutic Areas

Anti-malarialAnti-infectivePain ManagementGastrointestinalNutraceuticals

Other Various Drugs

DrugCompanyPhase
Biosimilar ProgramsRichter GedeonPhase 3
Oligonucleotide APIsBachemClinical/Commercial
Novel Plasma-derived TherapiesTiantan BioPre-clinical
Complex Injectable Generics PipelineAmphastar PharmaceuticalsANDA Filed / Development
Generic PortfolioStrides PharmaApproved
New Product LaunchesFDC IndiaDevelopment/Filing
Generic Products PortfolioCelon PharmaApproved/Commercial
Pipeline of Complex GenericsMayne Pharma GroupDevelopment
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved